Skip to main content Accessibility help
  • Print publication year: 2013
  • Online publication date: June 2014


Related content

Powered by UNSILO

Suggested reading

Anonymous. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy: Canadian Study Group for Childhood Epilepsy. Epilepsia 1998; 39: 952–959.
Conry JA, Ng YT, Paolicchi JM, Kernitsky L, Mitchell WG, Ritter FJ, Collins SD, Tracy K, Kormany WN, Abdulnabi R, Riley B, Stolle J. Clobazam in the treatment of Lennox-Gastaut syndrome. Epilepsia 2009; 50: 1158–1166.
Feely M, Gibson J. Intermittent clobazam for catamenial epilepsy: tolerance avoided. Journal of Neurology, Neurosurgery, and Psychiatry 1984; 47: 1279–1282.
Kinoshita M, Ikeda A, Begum T, Terada K, Shibashaki H. Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB. Journal of Neurological Sciences 2007; 263: 44–48.
Mechndiratta MM, Krishnamurthy M, Rajesh KN, Singh G. Clobazam monotherapy in drug naïve adult patients with epilepsy. Seizure 2003; 12: 226–228.
Ng YT, Collins SD. Clobazam. Neurotherapeutics 2007; 4: 138–144.
Patsalos PN. Antiepileptic drug interactions – A clinical guide. 2nd Edition. 2013, Springer, London, UK; 2013.
Riss J, Cloyd J, Gates J, Collins S. Benzodiazepines in epilepsy: pharmacology and pharmacokinetics. Acta Neurologica Scandinavica 2008; 118: 69–86.
Sennoune S, Mesdjian E, Bonneton J, Genton P, Dravet C, Roger J. Interactions between clobazam and standard antiepileptic drugs in patients with epilepsy. Therapeutic Drug Monitoring 1992; 14: 269–274.
Silva RC, Montenegro MA, Guerreiro CA, Guerreiro MM. Clobazam as add-on therapy in children with epileptic encephalopathy. Canadian Journal of Neurological Sciences 2006; 33: 209–213.